Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 7, 1997, Pages 1233-1238

  Mackness, Bharti ^a,b   Hunt, Roger ^a   Durrington, Paul N ^a   Mackness, Michael I ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Clusterin; High density lipoprotein; Paraoxonase

Indexed keywords

APOLIPOPROTEIN A1; ARYLESTERASE; CLUSTERIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ADULT; AGED; AORTA; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LYSOSOME; MALE; OXIDATIVE STRESS; PEROXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER;

EID: 0030753875     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.7.1233     Document Type: Article

References (16)

1. Durrington PN. Hyperlipidaemia. Diagnosis and Management. 2nd ed. London, UK: Butterworth Heinemann; 1994.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
3. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
4. Steinbrecher UP, Lougheed M, Kwan W-C, Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J Biol Chem. 1989;264:15216-15223.
5. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
6. Stanton LW, White RT, Bryant CM, Protter AA, Endermann G. The macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem. 1992;267:22446-22451.
7. Bocan TMA, Brown SA, Guyton JR. Human aortic fibrolipid lesions: immunochemical localization of apolipoprotein B and apolipoprotein A. Arteriosclerosis. 1988;8:499-508.
8. Kaesberg B, Harrach B, Dieplinger H, Robenek H. In situ immunolocalization of lipoproteins in human arteriosclerotic tissue. Arterioscler Thromb. 1993;13:133-146.
9. Jürgens G, Chen Q, Esterbauer H, Mair S, Ledinski G, Dinges HP. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler Thromb. 1993;13:1689-1699.
10. Reblin T, Myer N, Labeur C, Henne-Bruns D, Beisiegel U. Extraction of lipoprotein(a), apoB, and apoE from fresh human arterial wall and atherosclerotic plaques. Atherosclerosis. 1995;113:179-188.
11. Smith EB, Cochran S. Factors influencing the accumulation of fibrous plaques of lipid derived from low-density lipoprotein, II: preferential immobilization of lipoprotein(a). Atherosclerosis. 1990;84:173-181.
12. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991;286:152-154.
13. Mackness MI, Arrol S, Abbott CA, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 1993;104:129-135.
14. Watson AD, Berliner JA, Hama SY, LaDu BN, Fault KF, Fogelman AM, Navab M. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low-density lipoprotein. J Clin Invest. 1995;96:2882-2891.
15. Jordan-Starck TC, Witte DP, Aronow BJ, Harmony JAK. Apolipoprotein J: a membrane policeman? Curr Opin Lipidol. 1992;3:75-85.
16. Rosenberg ME, Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol. 1995;27:633-645.